We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
-3.41%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$161M
AUM Growth
-$12.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EYPT icon
1
EyePoint Inc
EYPT
$1.13B
$75.9M 47.25%
4,190,922
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$43.4M 27.06%
3,342,047
AXGN icon
3
Axogen
AXGN
$2.61B
$30.3M 18.89%
2,429,999
MNOV icon
4
MediciNova
MNOV
$65M
$9.54M 5.94%
1,170,370
ELGX
5
DELISTED
Endologix Inc
ELGX
$998K 0.62%
125,747
GYRE icon
6
Gyre Therapeutics
GYRE
$704M
$386K 0.24%
10,483

Similar funds

Essex Woodlands Management's Q3 2019 Portfolio in Review

As of Q3 2019, Essex Woodlands Management held 6 positions worth $161M, down 7.4% from $173M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. Essex Woodlands Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

  • Essex Woodlands Management's ten largest holdings make up 100% of its $161M portfolio in Q3 2019.
  • Essex Woodlands Management opened 0 new positions and closed 0 in Q3 2019.
  • Essex Woodlands Management's portfolio value fell 7.4% quarter-over-quarter to $161M.

Based on Essex Woodlands Management's 13F filing for Q3 2019, filed 14 Nov 2019.